Incident and Prevalent Use of Alvimopan, Naltrexone, and Methylnaltrexone

    Basic Details
    Date Posted
    Sunday, November 23, 2014
    Status
    In progress
    Medical Product
    alvimopan
    methylnaltrexone bromide
    morphine sulfate/naltrexone
    naltrexone
    naltrexone HCL
    naltrexone microsphere
    Description

    Summary table assessment of the incident and prevalent use of six generic drug products: Alvimopan, Methylnaltrexone Bromide, Morphine Sulfate/Naltrexone, Naltrexone, Naltrexone HCL, and Naltrexone Microspheres. Results were generated using the Mini-Sentinel Distributed Query Tool and the Dispensing Summary Table. Summary tables are precompiled stratified counts. Queries were executed on October 24, 2013. This report includes data from 17 Data Partners.

    If you are using a web page screen reader and are unable to access this document, please contact the Mini-Sentinel Operations Center for assistance by clicking on the Submit Comments link above or sending an email requesting assistance to info@mini-sentinel.org.

    The information contained on this website is provided as part of FDA's commitment to place knowledge acquired from the Mini-Sentinel pilot in the public domain as soon as possible. Please read the disclaimer.

    Additional Details
    FDA Center
    CDER
    Time Period
    2001-2013
    Study Type
    Summary Table
    Assessment Type
    Exploratory Analyses
    Data Sources
    Mini-Sentinel Distributed Database (MSDD)